Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

11,938 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Analysis of Coronary Arterial Aneurysm Regression in Patients With Kawasaki Disease by Aneurysm Severity: Factors Associated With Regression.
Kato T, Miura M, Kobayashi T, Kaneko T, Fukushima N, Suda K, Maeda J, Shimoyama S, Shiono J, Hirono K, Ikeda K, Sato S, Numano F, Mitani Y, Waki K, Ayusawa M, Fukazawa R, Fuse S; Z‐Score Project 2nd Stage Study Group *. Kato T, et al. Among authors: sato s. J Am Heart Assoc. 2023 Feb 7;12(3):e022417. doi: 10.1161/JAHA.121.022417. Epub 2023 Jan 31. J Am Heart Assoc. 2023. PMID: 36718857 Free PMC article.
Prognosis of Indolent Adult T-Cell Leukemia/Lymphoma.
Kameda T, Shide K, Tahira Y, Sekine M, Sato S, Ishizaki J, Takeuchi M, Akizuki K, Kamiunten A, Shimoda H, Toyama T, Maeda K, Yamashita K, Kawano N, Kawano H, Hidaka T, Yamaguchi H, Kubuki Y, Kitanaka A, Matsuoka H, Shimoda K. Kameda T, et al. Among authors: sato s. Viruses. 2022 Mar 29;14(4):710. doi: 10.3390/v14040710. Viruses. 2022. PMID: 35458440 Free PMC article.
Final 3-year Results of the Dasatinib Discontinuation Trial in Patients With Chronic Myeloid Leukemia Who Received Dasatinib as a Second-line Treatment.
Okada M, Imagawa J, Tanaka H, Nakamae H, Hino M, Murai K, Ishida Y, Kumagai T, Sato S, Ohashi K, Sakamaki H, Wakita H, Uoshima N, Nakagawa Y, Minami Y, Ogasawara M, Takeoka T, Akasaka H, Utsumi T, Uike N, Sato T, Ando S, Usuki K, Mizuta S, Hashino S, Nomura T, Shikami M, Fukutani H, Ohe Y, Kosugi H, Shibayama H, Maeda Y, Fukushima T, Yamazaki H, Tsubaki K, Kukita T, Adachi Y, Nataduka T, Sakoda H, Yokoyama H, Okamoto T, Shirasugi Y, Onishi Y, Nohgawa M, Yoshihara S, Morita S, Sakamoto J, Kimura S; DADI Trial Group, Japan. Okada M, et al. Among authors: sato s, sato t. Clin Lymphoma Myeloma Leuk. 2018 May;18(5):353-360.e1. doi: 10.1016/j.clml.2018.03.004. Epub 2018 Mar 15. Clin Lymphoma Myeloma Leuk. 2018. PMID: 29610029 Free article. Clinical Trial.
Prevalence of chromosome 8p11.2 translocations and correlation with myeloid and lymphoid neoplasms associated with FGFR1 abnormalities in a consecutive cohort from nine institutions in Japan.
Usuki K, Kameda T, Kawano N, Ito T, Hashimoto Y, Shide K, Kawano H, Sekine M, Toyama T, Iizuka H, Sato S, Takeuchi M, Ishizaki J, Maeda K, Nakai M, Yamashita K, Kubuki Y, Shimoda K. Usuki K, et al. Among authors: sato s. Int J Hematol. 2024 Mar 8. doi: 10.1007/s12185-024-03740-0. Online ahead of print. Int J Hematol. 2024. PMID: 38457113
Thrombohemorrhagic events, disease progression, and survival in polycythemia vera and essential thrombocythemia: a retrospective survey in Miyazaki prefecture, Japan.
Kamiunten A, Shide K, Kameda T, Sekine M, Kubuki Y, Ito M, Toyama T, Kawano N, Marutsuka K, Maeda K, Takeuchi M, Kawano H, Sato S, Ishizaki J, Akizuki K, Tahira Y, Shimoda H, Hidaka T, Yamashita K, Matsuoka H, Shimoda K. Kamiunten A, et al. Among authors: sato s. Int J Hematol. 2018 Jun;107(6):681-688. doi: 10.1007/s12185-018-2428-0. Epub 2018 Feb 27. Int J Hematol. 2018. PMID: 29488167
Effects of mogamulizumab in adult T-cell leukemia/lymphoma in clinical practice.
Sekine M, Kubuki Y, Kameda T, Takeuchi M, Toyama T, Kawano N, Maeda K, Sato S, Ishizaki J, Kawano H, Kamiunten A, Akizuki K, Tahira Y, Shimoda H, Shide K, Hidaka T, Kitanaka A, Yamashita K, Matsuoka H, Shimoda K. Sekine M, et al. Among authors: sato s. Eur J Haematol. 2017 May;98(5):501-507. doi: 10.1111/ejh.12863. Epub 2017 Mar 10. Eur J Haematol. 2017. PMID: 28152225
Higher average chemotherapy dose intensity improves prognosis in patients with aggressive adult T-cell leukemia/lymphoma.
Sekine M, Kameda T, Shide K, Maeda K, Toyama T, Kawano N, Takeuchi M, Kawano H, Sato S, Ishizaki J, Kukita T, Kamiunten A, Akizuki K, Tahira Y, Shimoda H, Hidaka T, Yamashita K, Matsuoka H, Kitanaka A, Kubuki Y, Shimoda K. Sekine M, et al. Among authors: sato s. Eur J Haematol. 2021 Mar;106(3):398-407. doi: 10.1111/ejh.13565. Epub 2020 Dec 19. Eur J Haematol. 2021. PMID: 33301622
Real-World Data on Clinical Features, Outcomes, and Prognostic Factors in Multiple Myeloma from Miyazaki Prefecture, Japan.
Akizuki K, Matsuoka H, Toyama T, Kamiunten A, Sekine M, Shide K, Kameda T, Kawano N, Maeda K, Takeuchi M, Kawano H, Sato S, Ishizaki J, Tahira Y, Shimoda H, Hidaka T, Yamashita K, Kubuki Y, Shimoda K. Akizuki K, et al. Among authors: sato s. J Clin Med. 2020 Dec 30;10(1):105. doi: 10.3390/jcm10010105. J Clin Med. 2020. PMID: 33396800 Free PMC article.
11,938 results
You have reached the last available page of results. Please see the User Guide for more information.